MERGE, a premium storytelling and technology company, announced today that it has been named to the MM+M 2022 Agency 100. MERGE advanced four spots to no. 15.
The Agency 100 recognizes the top agencies, from boutique to multinational, in medical marketing and communications, putting MERGE among the industry elite. Nominees are selected based on their annual revenue. Each agency is highlighted in an individual, staff-written profile in MM+M's June "Agency 100" issue that allows them to showcase their uniqueness and differentiate themselves from their competitors.
"MERGE strives to connect science with soul in measurable ways," said Pat McGloin, Chief Client Officer for MERGE. "Our ability to blend storytelling and technology is what sets our work apart. Taking a systems architecture approach to brand building ensures that all of our HCP and patient focused tactics are working together in strengthening our clients’ brands. Over the past year, our team has created award-winning work for our clients in pharma, medical devices, diagnostics, and beyond. We are proud that these efforts have been recognized by MM+M, and thrilled that our hard work has been rewarded with a four-point increase in the rankings."
Since its founding in 1989, the MERGE team of poets + PhDs have built and supported successful healthcare brands. With over 100 successful pharmaceutical launches to date, MERGE has launched seven products in the last five years as the agency of record for new drug classes, challengers, and global brands.
For more on what MERGE can do for your brand, get in touch with us.